• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新诊断 2 型糖尿病患者血清可溶性 Fas(sFas)和可溶性 Fas 配体(sFasL)与胰岛素抵抗、β细胞功能和胰岛素敏感性的相关性。

Correlation of insulin resistance, beta cell function and insulin sensitivity with serum sFas and sFasL in newly diagnosed type 2 diabetes.

机构信息

Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221 005, India.

出版信息

Acta Diabetol. 2013 Aug;50(4):511-8. doi: 10.1007/s00592-011-0307-8. Epub 2011 Jun 22.

DOI:10.1007/s00592-011-0307-8
PMID:21695404
Abstract

Pancreatic beta cell dysfunction and reduced insulin sensitivity are fundamental factors associated with glucotoxicity, lipotoxicity and oxidative stress in type 2 diabetic patients (T2DM). Diabetic milieu can induce apoptosis in several types of cells. The aim of present study was to compare circulating soluble apoptotic markers (sFas and sFas-L) with HOMA-IR, HOMA-%S, HOMA-%B in the serum of newly diagnosed T2DM and healthy subjects. For this study, 94 T2DM and 60 healthy subjects were enroled and evaluated for various parameters. Biochemical quantifications were performed with Syncron CX5 auto-analyzer. The levels of serum sFas-L, TNF-α and IL-6 were estimated by flowcytometry. The fasting serum insulin and sFas quantified by ELISA. HOMA-IR, HOMA-%S and HOMA-%B were calculated with HOMA calculator v2.2.2. The levels of TC, TG, LDL-C, VLDL-C were augmented and HDL declined significantly (P < 0.001) in diabetics. The levels of serum insulin, TNF-α, IL-6, sFas, HOMA-IR were raised (P < 0.001) and sFas-L, HOMA-%S and HOMA-%B were decreased significantly (P < 0.001) in T2DM subjects than healthy. In diabetics, serum sFas was positively correlated with HOMA-IR (r = 0.720, P < 0.001) and negatively with HOMA-%B (r = -0.642, P < 0.001) significantly while serum sFasL was negatively correlated with HOMA-IR (r = -0.483, P < 0.001) and positively with HOMA-%B (r = 0.466, P < 0.001) significantly. Further, the multivariate stepwise regression analysis shows that HOMA-IR contributes significantly to the variance of sFas and sFasL. Our findings suggest that the pancreatic beta cell dysfunction along with increased insulin resistance appears to be associated with apoptotic markers.

摘要

胰腺β细胞功能障碍和胰岛素敏感性降低是与 2 型糖尿病患者(T2DM)的糖毒性、脂毒性和氧化应激相关的基本因素。糖尿病环境可诱导多种细胞凋亡。本研究旨在比较新诊断的 T2DM 患者和健康受试者血清中循环可溶性凋亡标志物(sFas 和 sFas-L)与 HOMA-IR、HOMA-%S 和 HOMA-%B 的相关性。为此,本研究纳入了 94 例 T2DM 患者和 60 例健康对照者,并对其进行了各项参数评估。生化定量采用 Syncron CX5 自动分析仪进行。通过流式细胞术检测血清 sFas-L、TNF-α 和 IL-6 水平。采用 ELISA 法检测空腹血清胰岛素和 sFas 水平。采用 HOMA 计算器 v2.2.2 计算 HOMA-IR、HOMA-%S 和 HOMA-%B。结果显示,糖尿病患者 TC、TG、LDL-C 和 VLDL-C 水平显著升高(P < 0.001),HDL 水平显著降低(P < 0.001)。与健康对照组相比,T2DM 患者血清胰岛素、TNF-α、IL-6、sFas 和 HOMA-IR 水平升高(P < 0.001),sFas-L、HOMA-%S 和 HOMA-%B 水平降低(P < 0.001)。在糖尿病患者中,血清 sFas 与 HOMA-IR 呈正相关(r = 0.720,P < 0.001),与 HOMA-%B 呈负相关(r = -0.642,P < 0.001),而血清 sFasL 与 HOMA-IR 呈负相关(r = -0.483,P < 0.001),与 HOMA-%B 呈正相关(r = 0.466,P < 0.001)。进一步的多元逐步回归分析表明,HOMA-IR 对 sFas 和 sFasL 的变化有显著贡献。本研究结果提示,胰腺β细胞功能障碍伴胰岛素抵抗增加可能与凋亡标志物有关。

相似文献

1
Correlation of insulin resistance, beta cell function and insulin sensitivity with serum sFas and sFasL in newly diagnosed type 2 diabetes.新诊断 2 型糖尿病患者血清可溶性 Fas(sFas)和可溶性 Fas 配体(sFasL)与胰岛素抵抗、β细胞功能和胰岛素敏感性的相关性。
Acta Diabetol. 2013 Aug;50(4):511-8. doi: 10.1007/s00592-011-0307-8. Epub 2011 Jun 22.
2
[Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].2型糖尿病一级亲属中抵抗素、内脂素与胰岛素抵抗及β细胞功能的相关性
Zhonghua Liu Xing Bing Xue Za Zhi. 2010 Dec;31(12):1393-6.
3
[Serum APPL1 level is elevated in newly diagnosed cases of type 2 diabetes mellitus].[血清APPL1水平在新诊断的2型糖尿病病例中升高]
Nan Fang Yi Ke Da Xue Xue Bao. 2012 Sep;32(9):1373-6.
4
Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.慢性肾衰竭患者血清可溶性Fas(CD95)和Fas配体水平分析
J Lab Clin Med. 2000 Oct;136(4):320-7. doi: 10.1067/mlc.2000.109318.
5
Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.巴西肥胖或有2型糖尿病风险因素的青少年的胰岛素抵抗、β细胞功能和糖耐量。
J Diabetes Complications. 2007 Mar-Apr;21(2):84-92. doi: 10.1016/j.jdiacomp.2005.11.006.
6
Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians.血浆脂联素水平与肥胖、炎症、血脂和 2 型糖尿病及非糖尿病特立尼达人体内的胰岛素有关。
Prim Care Diabetes. 2010 Oct;4(3):187-92. doi: 10.1016/j.pcd.2010.05.006. Epub 2010 Jun 30.
7
Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.血清胰岛素样生长因子-1(IGF-1)水平与丙型肝炎病毒感染和胰岛素抵抗的关系。
Transl Res. 2011 Sep;158(3):155-62. doi: 10.1016/j.trsl.2011.04.005. Epub 2011 May 30.
8
Cut-off points of homeostasis model assessment of insulin resistance, beta-cell function, and fasting serum insulin to identify future type 2 diabetes: Tehran Lipid and Glucose Study.胰岛素抵抗、β细胞功能及空腹血清胰岛素稳态模型评估的切点用于识别未来2型糖尿病:德黑兰血脂与血糖研究
Acta Diabetol. 2015 Oct;52(5):905-15. doi: 10.1007/s00592-015-0730-3. Epub 2015 Mar 22.
9
[Clinical significances of serum soluble fas and soluble fas ligand in chronic hepatitis B].[血清可溶性Fas及可溶性Fas配体在慢性乙型肝炎中的临床意义]
Korean J Hepatol. 2006 Dec;12(4):507-14.
10
[The effect and mechanism of transient continuous subcutaneous insulin infusion therapy on beta cell function, insulin resistance and vascular endothelial injury in newly diagnosed type 2 diabetes].持续皮下胰岛素输注治疗对新诊断2型糖尿病患者胰岛β细胞功能、胰岛素抵抗及血管内皮损伤的影响及机制
Zhonghua Nei Ke Za Zhi. 2010 May;49(5):405-9.

引用本文的文献

1
Click Reaction Inspired Enzyme Inhibitors in Diabetes Care: An Update in the Field of Chronic Metabolic Disorder.点击反应启发的糖尿病护理中的酶抑制剂:慢性代谢紊乱领域的最新进展
Curr Pharm Des. 2025;31(4):261-291. doi: 10.2174/0113816128310031240923062555.
2
Modulation of the Cellular microRNA Landscape: Contribution to the Protective Effects of High-Density Lipoproteins (HDL).细胞微小RNA格局的调控:对高密度脂蛋白(HDL)保护作用的贡献
Biology (Basel). 2023 Sep 13;12(9):1232. doi: 10.3390/biology12091232.
3
MicroRNA Sequences Modulated by Beta Cell Lipid Metabolism: Implications for Type 2 Diabetes Mellitus.
受β细胞脂质代谢调节的微小RNA序列:对2型糖尿病的影响
Biology (Basel). 2021 Jun 15;10(6):534. doi: 10.3390/biology10060534.
4
Protection against Glucolipotoxicity by High Density Lipoprotein in Human PANC-1 Hybrid 1.1B4 Pancreatic Beta Cells: The Role of microRNA.高密度脂蛋白对人PANC-1杂交1.1B4胰腺β细胞糖脂毒性的保护作用:微小RNA的作用
Biology (Basel). 2021 Mar 13;10(3):218. doi: 10.3390/biology10030218.
5
High expression of CD52 in adipocytes: a potential therapeutic target for obesity with type 2 diabetes.脂肪细胞中 CD52 的高表达:2 型糖尿病肥胖症的潜在治疗靶点。
Aging (Albany NY). 2021 Mar 11;13(8):11043-11060. doi: 10.18632/aging.202714.
6
Deep Learning for Integrated Analysis of Insulin Resistance with Multi-Omics Data.用于胰岛素抵抗与多组学数据综合分析的深度学习
J Pers Med. 2021 Feb 15;11(2):128. doi: 10.3390/jpm11020128.
7
Fas-Associated Factor 1 Promotes Hepatic Insulin Resistance via JNK Signaling Pathway.Fas 相关因子 1 通过 JNK 信号通路促进肝脏胰岛素抵抗。
Oxid Med Cell Longev. 2021 Jan 16;2021:3756925. doi: 10.1155/2021/3756925. eCollection 2021.
8
Adipokine levels and their association with insulin resistance and fetal outcomes among the newborns of Indian gestational diabetic mothers.印度妊娠期糖尿病母亲新生儿的脂肪因子水平及其与胰岛素抵抗和胎儿结局的关联。
Saudi Med J. 2019 Apr;40(4):353-359. doi: 10.15537/smj.2019.4.24058.
9
Correlation Between Glycated Hemoglobin and Homa Indices in Type 2 Diabetes Mellitus: Prediction of Beta-Cell Function from Glycated Hemoglobin.2型糖尿病患者糖化血红蛋白与稳态模型评估指标的相关性:基于糖化血红蛋白预测β细胞功能
J Med Biochem. 2015 Apr;34(2):191-199. doi: 10.2478/jomb-2014-0033. Epub 2015 Mar 3.
10
Evaluation of diabetic polyneuropathy in Type 2 diabetes mellitus by nerve conduction study and association of severity of neuropathy with serum sFasL level.通过神经传导研究评估2型糖尿病患者的糖尿病性多发性神经病以及神经病变严重程度与血清可溶性Fas配体(sFasL)水平的相关性。
Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S465-7. doi: 10.4103/2230-8210.104133.